Results 1 to 10 of about 17,756 (269)

Adherence to Clotting Factor Prophylaxis in Adolescent and Adult Males With Haemophilia. [PDF]

Haemophilia
ABSTRACT Introduction Clotting factor prophylaxis remains the most prescribed standard‐of‐care treatment for people with haemophilia (PwH). Prophylaxis prevents bleeds, joint damage, and improves quality of life (QoL). Its success depends on treatment adherence, consisting of socioeconomic, behavioural, and disease‐ or therapy‐related factors.
Beserra NM, Camelo RM, Sacramento AOR, Nascimento ES, Machado RPG, Gonçalves Machado CM, Dantas SMC, Rocha SGMD, Carvalho LEM, Lemes RPG.   +9 more
europepmc   +2 more sources

Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials. [PDF]

Hemasphere
González-Gil C, Lopes T, Morgades M, Fuster-Tormo F, Montesinos P, Medina CR, Hermosín L, González-Martínez T, Queipo MP, González-Campos J, Martínez-Sánchez P, Díaz-Beya M, Coll R, Maluquer C, Zamora L, Artola T, Vall-Llovera F, Tormo M, Torrent A, Martínez-Laperche C, Gil-Cortés C, Barba P, Cervera M, Ribera J, Fernández-Delgado M, Ayala R, Cladera A, Mateos MC, Vidal MJ, Feliu J, Torres A, Azaceta G, Calasanz MJ, Bigas A, Esteller M, Orfao A, Ribera JM, Genescà E.   +37 more
europepmc   +1 more source

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk. [PDF]

Br J Haematol
Marín-Quílez A, Sánchez-Fuentes A, Zamora-Cánovas A, Gómez-González PL, Diaz-Ajenjo L, Benito R, Rodríguez-Alén A, Sevivas T, Murciano T, Murillo L, Butta NV, Revilla N, Campos R, Escribano P, Esteve J, Fernández-Mosteirin N, Ferrer-Marín F, Hernández L, Huerta-Aragonés J, León A, López-Duarte M, López E, Martín-Salces M, Nomdedeu M, Oña R, Peláez-Pleguezuelos I, Ramos F, Sebastián E, Serrano C, Sierra-Aisa C, Vidal-Laso R, González-Porras JR, Lozano ML, Bastida JM, Rivera J.   +34 more
europepmc   +1 more source

Association of Toxoplasma gondii infection with hematological parameters and CD4⁺ cell counts among pregnant women attending antenatal care in a public hospital of Northwest Ethiopia. [PDF]

Hematol Transfus Cell Ther
Woldegerima E, Birhan M, Melese M, Tesshome DF, Dagnaw M, Wondmagegn T, Berhane N.   +6 more
europepmc   +1 more source

Cost-Effectiveness analysis of the 21-Gene platform for guiding treatment decisions for early Hormone-Positive breast cancer: the perspective of the Brazilian public health system. [PDF]

BMC Health Serv Res
de Iracema Gomes Cubero D, Fonseca FLA, da Costa Aguiar Alves Reis B, de Alcantara Sousa LV, Maselli-Schoueri JH, da Giglio A.   +5 more
europepmc   +1 more source

Developing infographics to implement patient blood management in the surgical pathway: From concept to design. [PDF]

Hematol Transfus Cell Ther
Moitinho MS, Meneghini B, Monteiro R, Manucci A, Guido MC, Rabello G, Jatene FB.   +6 more
europepmc   +1 more source

Potentially malignant oral disorders in patients with fanconi anemia: A cross-sectional study. [PDF]

Hematol Transfus Cell Ther
Vendruscolo JL, Ballardin BS, Schussel JL, Torres-Pereira CC.   +3 more
europepmc   +1 more source

Reply to Omansen, T.F.; Ramharter, M. Intensive Therapeutic Plasma Exchange for Severe Yellow Fever: What Is the Evidence? Comment on "Ho et al. Intensive Therapeutic Plasma Exchange-New Approach to Treat and Rescue Patients with Severe Form of Yellow Fever. <i>Trop. Med. Infect. Dis.</i> 2025, <i>10</i>, 39". [PDF]

Trop Med Infect Dis
Ho YL, Nukui Y, Villaça PR, Okazaki E, Tatsui NH, Netto LC, Joelsons D, da Rocha TRF, de Mello Malta F, Pinho JRR, Segurado AAC, Rocha V.   +11 more
europepmc   +1 more source

Symptomatic Vulvar Primary Cutaneous Amyloidosis Associated With Low-Risk HPV: A Case Report. [PDF]

Clin Case Rep
Hoegl J, Fernandes A, Marquez D, Silva Y.   +3 more
europepmc   +1 more source